STOCK TITAN

4Front Ventures to Report Third Quarter 2021 Financial Results on November 17, 2021

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

4Front Ventures Corp (CSE: FFNT, OTCQX: FFNTF) will release its third-quarter financial results for the period ending September 30, 2021, on November 17, 2021, after market close. Following the report, a conference call is scheduled at 5:00 p.m. Eastern Time to discuss the outcomes and current business trends. 4Front Ventures operates in key cannabis markets, including California and Massachusetts, and boasts a portfolio of over 20 cannabis brands and 1800 products. The company aims to enhance shareholder value with its extensive industry expertise.

Positive
  • Established a strong reputation with over 20 cannabis brands and 1800 products.
  • Vertically integrated operations across multiple key cannabis markets.
  • Upcoming earnings report may reveal positive financial trends.
Negative
  • None.

PHOENIX, Nov. 10, 2021 /PRNewswire/ - 4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) ("4Front" or the "Company"), a vertically integrated, multi-state cannabis operator and retailer, will report financial results for the third quarter ended September 30, 2021 on Wednesday, November 17, 2021 after market close. The Company will host a conference call to discuss the results and provide an update on current business trends at 5:00 p.m. Eastern Time.

Conference Call Details

DATE:

Wednesday, November 17, 2021

TIME:

5:00 p.m. Eastern Time

U.S./CANADA TOLL-FREE DIAL-IN:

1-866-248-8441

WEBCAST:

The conference call will be broadcast live and available for replay at this link.

REPLAY:

A telephonic replay of the conference call will be available until Wednesday, December 1, 2021.

Toll-free replay number: 1-888-203-1112

Replay entry code: 1662764

INTERNATIONAL DIAL-IN ASSISTANCE:

Contact IR@4FrontVentures.com

About 4Front Ventures Corp.

4Front Ventures Corp. ("4Front" or the "Company") (CSE: FFNT) (OTCQX: FFNTF) is a national, vertically integrated multi-state cannabis operator who owns or manages operations and facilities in strategic medical and adult-use cannabis markets, including California, Illinois, Massachusetts, Michigan and Washington. Since its founding in 2011, 4Front has built a strong reputation for its high standards and low-cost cultivation and production methodologies earned through a track record of success in facility design, cultivation, genetics, growing processes, manufacturing, purchasing, distribution, and retail. To date, 4Front has successfully brought to market more than 20 different cannabis brands and over 1800 products, which are strategically distributed through its fully owned and operated "Mission Dispensaries" and retail outlets in its core markets. As the Company continues to drive value for its shareholders, its team is applying its decade of expertise in the sector across the cannabis industry value chain and ecosystem. For more information, visit www.4frontventures.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/4front-ventures-to-report-third-quarter-2021-financial-results-on-november-17-2021-301421684.html

SOURCE 4Front

FAQ

When will 4Front Ventures report its third-quarter financial results for 2021?

4Front Ventures will report its third-quarter financial results on November 17, 2021.

What time is the conference call for 4Front Ventures' financial results?

The conference call is scheduled for 5:00 p.m. Eastern Time on November 17, 2021.

What is the ticker symbol for 4Front Ventures on the OTCQX?

The ticker symbol for 4Front Ventures on the OTCQX is FFNTF.

What markets does 4Front Ventures operate in?

4Front Ventures operates in key cannabis markets including California, Illinois, Massachusetts, Michigan, and Washington.

How many products does 4Front Ventures offer?

4Front Ventures offers over 1800 products across its cannabis brands.

4FRONT VENTURES CORP

OTC:FFNTF

FFNTF Rankings

FFNTF Latest News

FFNTF Stock Data

47.58M
426.35M
47.54%
6.78%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Phoenix